Seres Therapeutics, Inc. (MCRB)
NASDAQ · Manufacturing · Pharmaceutical preparations
$3.53−$0.0900 (−2.49%) on the dayAs of the close; data may be delayed.
MCRB price, last 12 months
Key stats
- Previous close
- $3.62
- Open
- $3.76
- Day range
- $3.50 – $3.76
- 52-week range
- $3.50 – $29.98
- Volume
- 46.9K
- Avg volume (20 days)
- 54.7K
- Market cap
- $35.4M
Performance
1W−11.8%
1M−25.8%
3M−50.1%
6M−62.2%
YTD−76.3%
1Y−81.8%
vs S&P 500, 1Y−98.6 pts
Technicals and fundamentals
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $35.4M